bioMerieux (FR:BIM) has released an update. bioMerieux has received FDA clearance for its VIDAS® TBI test, designed to improve the management of patients with mild traumatic brain injury by predicting ...
Please provide your email address to receive an email when new articles are posted on . The distance horizontal fusional facility test identified patients with acquired brain injuries. Future testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results